BioCentury

Current Editions

January 27, 2026
2026 Catalysts: Psychiatry, epilepsy and neurodegeneration

A selection of clinical and regulatory milestones to watch in 2026

Product Development

Product Development

Broadening T cell control in atopic dermatitis

Data from Corvus and Sanofi probe the potential advantages of blocking upstream T cell activation instead of downstream cytokine pathways 

BioCentury ISSN 1097-7201